₦airaland Forum

SohSoh:
my " BUY " recommendation on MeCure Industries Plc is based on a combination of strong fundamentals and prudent financial management. Despite the repayment of a significant portion of their commercial paper obligations, the company has remained profitable, posting a ₦568.71 million net profit in Q1 2025 and delivering 65% year-on-year revenue growth.

This reflects a resilient business model, disciplined capital allocation, and a management team that has demonstrated both operational efficiency and strategic foresight. The company's ability to grow earnings while meeting debt obligations is a key indicator of underlying strength—not just good management, but effective execution.

But their dividends paymet is very low na

You took this from my mouth

Sunrisepebble:
English
Fidson looks the better stock in that sector. Paid N1 from 2.something earnings. They can likely pay N2 for the next full year

fashionnisir:
Ellahlake that some people bad mouthed here some days ago , how do you expect it too move up dont you know the power of market sentiment in stock market.
why digging out her calls , when she cant control other People uncertainty.

is internet a joke to you?

Na breast problem Ellah get, according to Loco, not badmouthing.
Can you downmouth PRESCO in same sector for me?
PRESCO has breast, Ellah has none that Loco can see.

When Oando was to fly, it was accelerating the more it was badmouthed.

zendi:
Na breast problem Ellah get, according to Loco, not badmouthing.
Can you downmouth PRESCO in same sector for me?
PRESCO has breast, Ellah has none that Loco can see.

PRESCO has breast

Tell Loco to Start let see

Only 8k units traded today. Marketing of stockfish

megawealth01:
You took this from my mouth

Sunrisepebble:
Only 8k units traded today. Marketing of stockfish

Anyday I understand MECURE is the day I will start buying silently. That's when volume will start increasing

Is there any connection between FIDSON and MORRISON?

SohSoh:
my " BUY " recommendation on MeCure Industries Plc is based on a combination of strong fundamentals and prudent financial management. Despite the repayment of a significant portion of their commercial paper obligations, the company has remained profitable, posting a ₦568.71 million net profit in Q1 2025 and delivering 65% year-on-year revenue growth.

This reflects a resilient business model, disciplined capital allocation, and a management team that has demonstrated both operational efficiency and strategic foresight. The company's ability to grow earnings while meeting debt obligations is a key indicator of underlying strength—not just good management, but effective execution.

what are their line of productions, is their any ground breaking drugs discoveries on the pipeline , is there any drugs patient to the name of the company . Will there be found in time off health crises in fore front , just like covid 19 to be able to give sharehold returns? those are key question to be asked about the company bussines

megawealth01:
Anyday I understand MECURE is the day I will start buying silently. That's when volume will start increasing

Hmmm . Ololade Mr Mega.. the simple apparent meaning of your post is that your buying will increase volume

TOE

Opportunity to as ask ellah CEO questions tomorrow if you really want to know what is on ground.

If he will answer specifics na.... How do we send in questions?

crownprince2017:
Opportunity to as ask ellah CEO questions tomorrow if you really want to know what is on ground.

crownprince2017:
Opportunity to as ask ellah CEO questions tomorrow if you really want to know what is on ground.

Even the laff in his eyes suggests that he has been browsing these pages if he is not even crownprince2017.

Sell
https://nairametrics.com/2025/06/02/bad-loans-nigerian-listed-banks-incur-n3-77-trillion-in-loan-losses-since-2023-see-top-losers/

For people who have processed dividend mandate via the nibss platform, how did you make payment?

Pls anybody who is able to get across the ceo of ellahlakes. He should make sure he tell us the following
1.A well detailed location of the farm whr they have the palm fruits farm.I want to go verify myself
2 The specific number of palm fruits on the farm at this moment not the size of the land they have acquired
3.The present growth size of the palm fruits
4 As we don't know the species they planted. He should tell when they think it will be due for fruiting if they have not started
5 The present position of the oil mill
These are the important questions any other thin na jara

debeey87:
For people who have processed dividend mandate via the nibss platform, how did you make payment?

What payment again. It is suppose to be free

debeey87:
For people who have processed dividend mandate via the nibss platform, how did you make payment?

What payment are talking about?Is the charge of N215.? If it is that, it debited from the account you inputted to receive your dividend payment

zendi:
Even the laff in his eyes suggests that he has been browsing these pages if he is not even crownprince2017.

jokes apart. The guy looks like serious guyman. Thr is something hidden behind the smile and the eyes.He is looking seriously like one of my sec sch mates who was conny in nature

KarlTom:
UPDATE!
TOEWay
Direct: 1,462,796,256 units

https://doclib.ngxgroup.com/Financial_NewsDocs/175_Notification_Of_Share_Dealing_By_Insider_-_Tony_Elumelu,_CFR.pdf

This looks like an arranged buy off from a big fund exiting. Nevertheless it’s good to see TOE picking it up and supporting UBA stock price. Consistent steadily growing dividend is the best way forward.

BabsO2:
This looks like an arranged buy off from a big fund exiting. Nevertheless it’s good to see TOE picking it up and supporting UBA stock price. Consistent steadily growing dividend is the best way forward.

💯

BabsO2:
This looks like an arranged buy off from a big fund exiting. Nevertheless it’s good to see TOE picking it up and supporting UBA stock price. Consistent steadily growing dividend is the best way forward.

You could be right.
The guy for cause wahala for uba price if he was allowed to offload on the floor

AGAIN YOU GUYS ARE FAILING TO SEE THE POINT, MECURE INDUSTRIES PLC " CURRENTLY " IS A BETTER BUY THAN FIDSON,
WHICH IS WHY I'M RECOMENDING IT AS A CURRENT BUY RECOMMENDATION.

Sunrisepebble:
English
Fidson looks the better stock in that sector. Paid N1 from 2.something earnings. They can likely pay N2 for the next full year

WHO IS PAYING BIG DIVIDENDS LATELY, EVEN Champion breweries THAT MADE 21 BILLION IN EARNINGS AND 900MILLION + PROFIT ONLY PAID ABOUT 6KOBO

megawealth01:
But their dividends paymet is very low na

thebargainhunte:
When is Oando going to distribute our shares to us?? This is June already and the second batch of share distribution will commence this month.
Results we no see
Share distribution...

Update on Share Distribution.
Following Oando PLC's press release dated February 5, 2025, shareholders are entitled to receive 1 new ordinary share (50 kobo) for every 12 shares held as of the Tranche 1 Qualification Date. The Registrars are currently working closely with the NGX, SEC, and CSCS to facilitate the distribution of the first tranche. Please be assured that all shareholders listed on the register of members as of February 14, 2025, will receive their corresponding share allocations in due course.

SohSoh:
AGAIN YOU GUYS ARE FAILING TO SEE THE POINT, MECURE INDUSTRIES PLC " CURRENTLY " IS A BETTER BUY THAN FIDSON,
WHICH IS WHY I'M RECOMENDING IT AS A CURRENT BUY RECOMMENDATION.

Mecure Key Financials (Q1 2025)
- Profit After Tax (Q1 2025): ₦568.71 million
- Basic EPS (Q1 2025): ₦0.14 per share
- Shares Outstanding: 4,000,000,000
- Annualized EPS: ₦0.14 x 4 = ₦0.56 per share
- Total Equity (March 2025): ₦14,527,713,000
- Book Value Per Share: ₦14,527,713,000 / 4,000,000,000 = ₦3.63 per share

Valuation
1. P/E Multiple (Nigerian Pharma: 8x–12x)
P/E - Implied Value (₦)
8x - 0.56 x 8 = 4.48
10x - 0.56 x 10 = 5.60
12x - 0.56 x 12 = 6.72

2. Price/Book (P/B) Method
- Book Value Per Share: ₦3.63
- P/B Range (1.0x–1.5x): ₦3.63 – ₦5.45

Fidson Key Financials (Q1 2025)
- Profit After Tax (Q1 2025): ₦3,250,658,000
- Basic EPS (Q1 2025): 142 kobo = ₦1.42
- Shares Outstanding: 2,294,996,000 shares
- Annualized EPS: ₦1.42 x 4 = ₦5.68
- Total Equity (March 2025): ₦26,976,971,000
- Book Value per Share: ₦26,976,971,000 / 2,294,996,000 ≈ ₦11.76 per share

Valuation
1. P/E Multiple (Sector Range: 6x–10x)
P/E - Implied Fair Value (₦)
6x - 5.68 x 6 = 34.08
8x - 5.68 x 8 = 45.44
10x - 5.68 x 10 = 56.80

2. Price/Book (P/B) Method
- Book Value per Share: ₦11.76
- P/B Range (1x–1.5x): ₦11.76 – ₦17.64

My Opinion
- I intentionally used a lower multiple for Fidson just to show why it is fundamentally stronger than MeCure on both earnings and asset base.
- The market should and does price Fidson at a premium to MeCure, justified by higher profit, superior balance sheet, and a track record of sector leadership.
- If you are considering both as portfolio candidates, Fidson offers better downside protection (via asset base) and greater upside if sector multiples expand.
- MeCure remains investable at the lower band of sector multiples, especially if its cancer center and recent projects drive sustainable profit growth, but it is a “mid-tier” play versus Fidson’s “sector leader” status. Mecure is overvalued as it is. Best case it goes to 14 naira (26% upside) or it drops to 7 naira (37% down side)

Your analysis is sharp and well-structured, it demonstrates a clear understanding of valuation metrics, earnings quality, and risk-reward tradeoffs.

That said, I remain confident in my BUY recommendation on MeCure. While I respect your view that Fidson may offer stronger fundamentals at this time.

it’s a free market, and that’s the beauty of it. Differing views, based on distinct strategies and time horizons, are what make markets function.

now :: I'm a trader, just looking for my next take profit, if the stock goes up fine I'll take my profit and walk away, if it goes down, I'll take my loss and walk away, but so far my analysis, that I have used previously has allowed me to take trades like this.

""" explanation to the photos attached """

1: my entry price for custodian was @18.10 on 15 may 2025, and on17 May.
Nairametrics released that article as to why custodian might be undervalued, fast forward to 6 days ago, the CEO of Toyota brought 150Mn shares at 3Bn.
and recently, custodian was among the stock recommendation from Morgan capital.

All these i consider catalyst to cause the price to move up ward.


2: my buy and sell entry for UPL
3: My entry for champion, which crossed well over 100% return, I'm not an investor, looking to buy and hold for the next 2/3 years like someone said about CUTIX. I'm just looking for my next take profit.

bovali:
Mecure Key Financials (Q1 2025)
- Profit After Tax (Q1 2025): ₦568.71 million
- Basic EPS (Q1 2025): ₦0.14 per share
- Shares Outstanding: 4,000,000,000
- Annualized EPS: ₦0.14 x 4 = ₦0.56 per share
- Total Equity (March 2025): ₦14,527,713,000
- Book Value Per Share: ₦14,527,713,000 / 4,000,000,000 = ₦3.63 per share

Valuation
1. P/E Multiple (Nigerian Pharma: 8x–12x)
P/E - Implied Value (₦)
8x - 0.56 x 8 = 4.48
10x - 0.56 x 10 = 5.60
12x - 0.56 x 12 = 6.72

2. Price/Book (P/B) Method
- Book Value Per Share: ₦3.63
- P/B Range (1.0x–1.5x): ₦3.63 – ₦5.45

Fidson Key Financials (Q1 2025)
- Profit After Tax (Q1 2025): ₦3,250,658,000
- Basic EPS (Q1 2025): 142 kobo = ₦1.42
- Shares Outstanding: 2,294,996,000 shares
- Annualized EPS: ₦1.42 x 4 = ₦5.68
- Total Equity (March 2025): ₦26,976,971,000
- Book Value per Share: ₦26,976,971,000 / 2,294,996,000 ≈ ₦11.76 per share

Valuation
1. P/E Multiple (Sector Range: 6x–10x)
P/E - Implied Fair Value (₦)
6x - 5.68 x 6 = 34.08
8x - 5.68 x 8 = 45.44
10x - 5.68 x 10 = 56.80

2. Price/Book (P/B) Method
- Book Value per Share: ₦11.76
- P/B Range (1x–1.5x): ₦11.76 – ₦17.64

My Opinion
- I intentionally used a lower multiple for Fidson just to show why it is fundamentally stronger than MeCure on both earnings and asset base.
- The market should and does price Fidson at a premium to MeCure, justified by higher profit, superior balance sheet, and a track record of sector leadership.
- If you are considering both as portfolio candidates, Fidson offers better downside protection (via asset base) and greater upside if sector multiples expand.
- MeCure remains investable at the lower band of sector multiples, especially if its cancer center and recent projects drive sustainable profit growth, but it is a “mid-tier” play versus Fidson’s “sector leader” status. Mecure is overvalued as it is. Best case it goes to 14 naira (26% upside) or it drops to 7 naira (37% down side)

Opportunity cash at work
On June 1, 2025, NNFM released its 2024 financial report ending 31st March 2025, which, as expected, showed a modest dividend. While social media predicted a negative impact on the share price, I anticipated otherwise. The company's fundamentals remained strong, with an outstanding share count of 178.2 million, revenue of N35.39 billion, and a profit before tax of N2.89 billion, Total comprehensive income of 1.7B.
After reviewing the 93-page KPMG-certified report, I noticed that the most crucial information was strategically placed on the last page. As I had mentioned earlier, market makers were trying to manipulate minority shareholders into selling their valuable assets, hence the social medial impulses.
This played out on June 2, 2025, when the market opened with approximately 3.5 million unit offers at N126.02 and zero bids. I seized this opportunity to increase my holdings, deploying my opportunity cash effectively.
Inspired by Pa Emmanuel's advice on the importance of opportunity cash, I quickly converted my emergency fund from a money market fund to cash. With a single click on the I-invest app, N3 million was transferred to my bank account, and subsequently, I credited my brokerage account. This strategic move allowed me to capitalize on the market opportunity and join the 1.36% of shareholders owning 50,001 to 100,000 shares.
My goal is to create a legacy portfolio for generational wealth. By 2027, I aim to join the 1.12% of shareholders owning 100,001 to 500,000 shares of NNFM if the company is not delisted. With determination and strategic investing, I believe I can achieve this milestone.
May God bless and guide all self-investors, granting them wisdom, patience, and prosperity in their investment journeys.

moneymanager:
Sell
https://nairametrics.com/2025/06/02/bad-loans-nigerian-listed-banks-incur-n3-77-trillion-in-loan-losses-since-2023-see-top-losers/

When you read the report you would see that comparatively on the average, the bad loans seemed to have reduced significantly in Q1 2025. I think Q2 would give us even more perspective but so far 2025 doesn’t seem that bad compared to 2024.

SohSoh:
WHO IS PAYING BIG DIVIDENDS LATELY, EVEN Champion breweries THAT MADE 21 BILLION IN EARNINGS AND 900MILLION + PROFIT ONLY PAID ABOUT 6KOBO

You want a list ?

SonofElElyonRet:
You want a list ?